Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Vericel (VCEL) EBT Margin (2016 - 2025)

Historic EBT Margin for Vericel (VCEL) over the last 16 years, with Q3 2025 value amounting to 7.56%.

  • Vericel's EBT Margin rose 91100.0% to 7.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.12%, marking a year-over-year increase of 30600.0%. This contributed to the annual value of 4.43% for FY2024, which is 56300.0% up from last year.
  • Vericel's EBT Margin amounted to 7.56% in Q3 2025, which was up 91100.0% from 0.84% recorded in Q2 2025.
  • In the past 5 years, Vericel's EBT Margin ranged from a high of 26.47% in Q4 2024 and a low of 24.19% during Q2 2022
  • Moreover, its 5-year median value for EBT Margin was 8.88% (2024), whereas its average is 4.98%.
  • Within the past 5 years, the most significant YoY rise in Vericel's EBT Margin was 319200bps (2021), while the steepest drop was -255100bps (2021).
  • Vericel's EBT Margin (Quarter) stood at 8.84% in 2021, then skyrocketed by 42bps to 12.57% in 2022, then surged by 73bps to 21.68% in 2023, then rose by 22bps to 26.47% in 2024, then tumbled by -71bps to 7.56% in 2025.
  • Its EBT Margin stands at 7.56% for Q3 2025, versus 0.84% for Q2 2025 and 21.46% for Q1 2025.